Detlev Ganten
Voorzitter bij Charité - Universitätsmedizin Berlin
Actieve functies van Detlev Ganten
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Charité - Universitätsmedizin Berlin | Voorzitter | 01-01-2005 | - |
| Max Planck Institute of Colloids & Interfaces | Voorzitter | 01-01-2010 | - |
| GlycoUniverse GmbH & Co KGaA | Directeur/Bestuurslid | - | - |
Eckert & Ziegler AG
 Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Directeur/Bestuurslid | - | - |
| World Health Summit | President | 01-01-2009 | - |
| Max Planck Institute of Molecular Plant Physiology | Voorzitter | - | - |
Loopbaan van Detlev Ganten
Eerdere bekende functies van Detlev Ganten
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ECKERT & ZIEGLER SE | Directeur/Bestuurslid | 20-05-2009 | 29-05-2019 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Directeur/Bestuurslid | 01-01-1991 | 01-01-2004 |
| Université PSL | Directeur/Bestuurslid | - | - |
Opleiding van Detlev Ganten
| McGill University | Doctorate Degree |
| Eberhard Karls Universität Tübingen | Undergraduate Degree |
Statistieken
Internationaal
| Duitsland | 10 |
| Canada | 2 |
| Frankrijk | 2 |
Operationeel
| Director/Board Member | 5 |
| Chairman | 3 |
| President | 1 |
Sectoraal
| Consumer Services | 6 |
| Health Technology | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ECKERT & ZIEGLER SE | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| GlycoUniverse GmbH & Co KGaA | |
Eckert & Ziegler AG
Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Health Services |
| World Health Summit | |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
| Max Planck Institute of Molecular Plant Physiology |
- Beurs
- Insiders
- Detlev Ganten
- Ervaring
